Plain-English translation of NCT06911073 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial tested a postbiotic supplement—a specially formulated capsule containing beneficial compounds, herbs, and vitamins—to see whether it could help people lose weight and improve their metabolic health. Postbiotics are derived from beneficial bacteria and may help restore balance to the gut microbiome, which researchers believe plays a role in weight management and how the body controls appetite and blood sugar.
Obesity and being overweight contribute to serious health problems like type 2 diabetes and heart disease worldwide. Recent research suggests that imbalances in gut bacteria may be connected to weight gain and metabolic problems, so this medication was developed as a potential way to address these underlying issues.
Participants in this completed trial received either a daily capsule containing the postbiotic supplement or a matching placebo capsule, and they took it once per day for the duration of the study. They maintained their normal eating and exercise habits, avoided other probiotic supplements, and completed questionnaires and health assessments to measure any changes in weight, metabolism, and overall health. The trial used a double-blind design, meaning neither the participants nor the researchers knew who was receiving the active supplement versus the placebo until the study was finished.
AI-generated summary from trial data · Aug 16, 2026 · Not medical advice
United States
Sponsor
ResBiotic Nutrition, Inc.
Collaborators
Able Biolabs, LLC
Enrollment target
~80 participants
Started
May 2025
Primary completion
March 2026
Age range
18 Years – 65 Years
Last updated on clinicaltrials.gov in August 2026.